Prostate cancer incidence and outcomes among Vietnam veterans receiving care in the Veterans Health Administration

By afschroeder • July 20, 2025

Green-Lott AY, Wadhwa A, Bailey AV, Kwan L, Haroldsen CL, Shelton JB, Lewis MS, Beenhouwer DO, Chamie K, Rose BS, Maxwell KN, Nickols NG, Yamoah K, Kelley MJ, Rebbeck TR, Schoen M, Rettig MB, Iyer HS, Garraway IP. Prostate cancer incidence and outcomes among Vietnam veterans receiving care in the Veterans Health Administration. Cancer. 2025 Aug 1;131(15):e70007. doi: 10.1002/cncr.70007. PMID: 40682278; PMCID: PMC12274657.

Tags: Agent Orange, Hematology/Oncology, Infectious Diseases, military exposures, prostate cancer, Publications, Veterans Administration, Vietnam veterans

Actionable biomarker co-expression in advanced ovarian cancer: folate receptor alpha expression and related markers

Shachar EK, Silverstein J, Gornbein J, Salani R, Karlan BY, Chase DM. Actionable biomarker co-expression in advanced ovarian cancer: folate receptor alpha expression and related[...]

Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE

Rugo HS, Tolaney SM, Chan N, Borges G, Yerushalmi R, Sharifi MN, McHayleh W, Beck T, Vidula N, Hamilton E, Rinn KJ, O'Shaughnessy J, Curigliano[...]

Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-blind, phase 3 trial

Le X, Passaro A, Zhao Y, Huang Y, Laskin J, Rodriguez-Abreu D, Calles A, Bazhenova L, Lo Russo G, Leighl NB, Cappuzzo F, Girard N,[...]